Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.
about
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsThe effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopyCellular membrane accommodation to thermal oscillations in the coral Seriatopora caliendrumApplication of high-resolution 1H MAS NMR spectroscopy to the analysis of intact bones from mice exposed to gamma radiation.MR-visible lipids and the tumor microenvironmentQuantitative magnetization transfer studies of apoptotic cell death.Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.Phosphorylcholine-containing lipid molecular species profiling in biological tissue using a fast HPLC/QqQ-MS method.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cellsMagnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumorsAnti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell lineIn vivo detection of phospholipase C by enzyme-activated near-infrared probes.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenograftsTherapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopyInterplay of choline metabolites and genes in patient-derived breast cancer xenografts.MR evaluation of response to targeted treatment in cancer cells.Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.Characterization of 1H NMR detectable mobile lipids in cells from human adenocarcinomas.Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells.Early detection of radiation therapy response in non-Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging.Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET.Taurine: a potential marker of apoptosis in gliomas.Nonprotecting Group Synthesis of a Phospholipase C Activatable Probe with an Azo-Free Quencher.Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopyComparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell linesStudy of Trypanosoma cruzi epimastigote cell death by NMR-visible mobile lipid analysis
P2860
Q28486529-45C7AED0-C62D-4791-B83C-D8FEE777F32CQ28534609-22144D9F-7B11-4F77-894E-E62A66FDBA3FQ28542427-D719439E-B548-4F33-8354-125082DFB6CEQ33552000-1DFF5DB0-8FEE-414C-97B8-A267F6D596E7Q33888362-B6170D4C-2EB6-43B2-869A-67169EC2B627Q33939930-CE9CCBC7-8BD1-4E71-B744-749ACCE71214Q34249948-D19AD3F5-ED12-4E9F-B4B7-2A812AAF4774Q34419161-F6C6204E-7F6D-48E4-9034-A0FC2A152F17Q34989144-4A35A5D5-63E0-4134-B994-0F94DDFCB8FBQ35112020-CC8B64A0-395A-493E-8459-F0F74F1EC18FQ35374872-1B121A6C-B9EA-41D3-9CEF-0192BB7E0BB9Q35728009-CD8B3848-96FF-43EE-8D86-6404B1D160BBQ35799716-90632D88-1C5E-4236-9436-4B1147F53405Q35987985-627E360D-FD2E-49A4-B51E-578752F6E3B8Q36528232-8080A7D8-D31E-4E64-9834-9CD1AD4390A2Q36630017-1EA7D53F-09A7-4D77-9554-D989203B404EQ37638188-1E63FBB6-7316-4D1A-BA83-26BA9D97906EQ37689772-39B4AF3A-9B45-4F39-A2D4-D420C6D10BC3Q37851076-5992CD10-F31F-4029-8BF7-030214ADAD47Q37871191-9C5FB42C-FD0E-4A4D-862A-04F34D27E567Q38336321-CCF394FA-FDD1-42D4-B8C9-C0A0D2154E0FQ39078185-9120399B-9FDC-43B8-96B9-9FDCFB18802AQ39728530-A4446905-4381-41BD-B4C5-F0F16EF17FC7Q39884998-C6A5C3F9-FF6C-42D1-B09F-7BFC2417F4D7Q42441848-5EC0F68B-5ADB-47C2-BC19-776A389A8B48Q42851982-6208BF82-9D92-43B1-A926-35CEBCD99838Q42956858-0854387A-1D33-4FF0-9DFA-8ABE7824E823Q43066909-436D17BB-38A0-45E6-992C-9F398A591255Q43165528-CC24FE85-BD04-4147-92F1-BF2C5CB66241Q55438493-E75D4BAA-2700-4B72-848F-BD3D147BAEF6Q57097452-815757C5-7205-4AA3-BFDF-BF5A44D04152Q57184138-315A8CC5-1728-44D1-831B-F83716C5C4A7Q58869704-162C8AF3-6CF9-48A1-A409-6EC07EB87B48
P2860
Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Increases in NMR-visible lipid ...... n human prostate cancer cells.
@en
type
label
Increases in NMR-visible lipid ...... n human prostate cancer cells.
@en
prefLabel
Increases in NMR-visible lipid ...... n human prostate cancer cells.
@en
P2093
P1476
Increases in NMR-visible lipid ...... in human prostate cancer cells
@en
P2093
Dvorit Samid
Edward J Delikatny
Hyunsuk Shim
Janna P Wehrle
Jerry D Glickson
Matthew Milkevitch
Stephen Pickup
Ulrich Pilatus
P356
10.1016/J.BBALIP.2005.01.008
P577
2005-02-24T00:00:00Z